GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TalkMed Group Ltd (SGX:5G3) » Definitions » Price-to-Owner-Earnings

TalkMed Group (SGX:5G3) Price-to-Owner-Earnings : 13.83 (As of Apr. 28, 2024)


View and export this data going back to 2014. Start your Free Trial

What is TalkMed Group Price-to-Owner-Earnings?

As of today (2024-04-28), TalkMed Group's share price is S$0.415. TalkMed Group's Owner Earnings per Share (TTM) ended in Dec. 2023 was S$0.03. It's Price-to-Owner-Earnings for today is 13.83.


The historical rank and industry rank for TalkMed Group's Price-to-Owner-Earnings or its related term are showing as below:

SGX:5G3' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 12.41   Med: 20   Max: 31.3
Current: 14.31

During the past 12 years, the highest Price-to-Owner-Earnings of TalkMed Group was 31.30. The lowest was 12.41. And the median was 20.00.


SGX:5G3's Price-to-Owner-Earnings is ranked better than
66.17% of 266 companies
in the Healthcare Providers & Services industry
Industry Median: 20.39 vs SGX:5G3: 14.31

As of today (2024-04-28), TalkMed Group's share price is S$0.415. TalkMed Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was S$0.03. Therefore, TalkMed Group's PE Ratio for today is 16.60.

As of today (2024-04-28), TalkMed Group's share price is S$0.415. TalkMed Group's EPS without NRI for the trailing twelve months (TTM) ended in was S$0.03. Therefore, TalkMed Group's PE Ratio without NRI for today is 16.60.

During the past 12 years, TalkMed Group's highest PE Ratio without NRI was 31.79. The lowest was 3.37. And the median was 18.93.


TalkMed Group Price-to-Owner-Earnings Historical Data

The historical data trend for TalkMed Group's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TalkMed Group Price-to-Owner-Earnings Chart

TalkMed Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.00 21.75 18.57 16.67 13.10

TalkMed Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.57 - 16.67 - 13.10

Competitive Comparison of TalkMed Group's Price-to-Owner-Earnings

For the Medical Care Facilities subindustry, TalkMed Group's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TalkMed Group's Price-to-Owner-Earnings Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, TalkMed Group's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where TalkMed Group's Price-to-Owner-Earnings falls into.



TalkMed Group Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

TalkMed Group's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.415/0.03
=13.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TalkMed Group  (SGX:5G3) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


TalkMed Group Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of TalkMed Group's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


TalkMed Group (SGX:5G3) Business Description

Traded in Other Exchanges
N/A
Address
3 Mount Elizabeth, Mount Elizabeth Hospital Level 2, Singapore, SGP, 228510
TalkMed Group Ltd operates as an investment holding company. It is a provider of medical oncology, stem cell transplants and palliative care services, serving patients in Singapore and the region. Outside Singapore, the Group operates in Vietnam, Hong Kong and the People's Republic of China. The activities of the company are the provision of medical oncology services and palliative care healthcare services in Singapore. It is organized into three reportable operating segments, Oncology Services, Stem Cells Services and Cellular and gene therapy-related products and services. The company has operational footprints across Singapore, Hong Kong and Vietnam of which Singapore contributes the vast majority of total revenue. It generates maximum revenue from the Oncology services segment.

TalkMed Group (SGX:5G3) Headlines

No Headlines